14-41886802-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_152447.5(LRFN5):āc.177A>Cā(p.Ala59=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000863 in 1,614,110 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0048 ( 4 hom., cov: 32)
Exomes š: 0.00046 ( 5 hom. )
Consequence
LRFN5
NM_152447.5 synonymous
NM_152447.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.815
Genes affected
LRFN5 (HGNC:20360): (leucine rich repeat and fibronectin type III domain containing 5) This gene encodes a protein that belongs to the leucine-rich repeat and fibronectin type III domain-containing family of proteins. A similar protein in mouse, a glycosylated transmembrane protein, is thought to function in presynaptic differentiation. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 14-41886802-A-C is Benign according to our data. Variant chr14-41886802-A-C is described in ClinVar as [Benign]. Clinvar id is 3041312.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.815 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00476 (725/152350) while in subpopulation AFR AF= 0.0169 (704/41578). AF 95% confidence interval is 0.0159. There are 4 homozygotes in gnomad4. There are 339 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 725 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRFN5 | NM_152447.5 | c.177A>C | p.Ala59= | synonymous_variant | 3/6 | ENST00000298119.9 | NP_689660.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRFN5 | ENST00000298119.9 | c.177A>C | p.Ala59= | synonymous_variant | 3/6 | 1 | NM_152447.5 | ENSP00000298119 | P3 | |
LRFN5 | ENST00000554171.1 | c.177A>C | p.Ala59= | synonymous_variant | 5/7 | 1 | ENSP00000451067 | A1 | ||
LRFN5 | ENST00000554120.5 | c.177A>C | p.Ala59= | synonymous_variant | 3/4 | 5 | ENSP00000451897 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00476 AC: 725AN: 152232Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
725
AN:
152232
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00122 AC: 306AN: 251024Hom.: 3 AF XY: 0.000825 AC XY: 112AN XY: 135690
GnomAD3 exomes
AF:
AC:
306
AN:
251024
Hom.:
AF XY:
AC XY:
112
AN XY:
135690
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000457 AC: 668AN: 1461760Hom.: 5 Cov.: 33 AF XY: 0.000406 AC XY: 295AN XY: 727170
GnomAD4 exome
AF:
AC:
668
AN:
1461760
Hom.:
Cov.:
33
AF XY:
AC XY:
295
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00476 AC: 725AN: 152350Hom.: 4 Cov.: 32 AF XY: 0.00455 AC XY: 339AN XY: 74516
GnomAD4 genome
AF:
AC:
725
AN:
152350
Hom.:
Cov.:
32
AF XY:
AC XY:
339
AN XY:
74516
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
LRFN5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at